Core Insights - Ant Insurance has upgraded its flagship health insurance product "Good Insurance" series for 2025, expanding coverage to include international departments and special needs departments of 470 top-tier hospitals across China, as well as certain private hospitals for specific diseases like cancer [1] - The upgrade enhances outpatient medication reimbursement responsibilities and adds over 1,500 advanced drugs and medical devices, including all imported drugs and nearly 400 original research drugs, promoting accessibility to high-end medical services [1][2] - The upgraded "Good Insurance" series includes three core products catering to different age groups: adults, seniors, and children, ensuring comprehensive health protection for families [1] Product Features - The 2025 version of "Good Insurance" expands the outpatient drug list to include all drugs approved by the National Medical Products Administration in 2024, allowing reimbursement for outpatient purchases during hospitalization [2] - The series introduces "exclusive family doctor services," which provide family health consultations and a dedicated advanced medicine hotline, enabling personalized medical advice and coordination with national hospitals and drug resources [2]
蚂蚁保“好医保”2025版升级 新增全国470家先进医院